Form4insider filings, from the source

SEC Form 4 · accession 0001104659-15-053971

Neos Therapeutics, Inc. · NEOS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Jul 28, 2015
Accepted (ET)
Jul 28, 2015 · 8:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001467652

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Jul 28, 2015C63,753—A63,753ISee Footnotes
Common StockF1,F2,F3Jul 28, 2015C205,825—A269,578ISee Footnotes
Common StockF1,F2,F3Jul 28, 2015C623,550—A893,128ISee Footnotes
Common StockF1,F2,F3Jul 28, 2015C14,230—A907,358ISee Footnotes

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series B Preferred StockF1,F2,F3—Jul 28, 2015C153,009D——Common Stock63,7530I
Series B-1 Preferred StockF1,F2,F3—Jul 28, 2015C493,982D——Common Stock205,8250I
Series C Preferred StockF1,F2,F3—Jul 28, 2015C1,496,521D——Common Stock623,5500I
Preferred Stock Warrant (Right to Buy)F4,F2,F3—Jul 28, 2015X170,766D——Series C Preferred Stock34,1530I
Series C Preferred StockF1,F2,F3—Jul 28, 2015C34,153D——Common Stock14,2300I

Explanation of responses